Blueprint Medicines Stock (NASDAQ: BPMC) stock price, news, charts, stock research, profile.
Open | $90.86 |
Close | $91.68 |
Volume / Avg. | 1.18M / 686.78K |
Day Range | $89.70 - $92.94 |
52 Wk Range | 43.89 - 121.90 |
Market Cap | $5.81B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 7.05% |
Days to Cover | 11.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Blueprint Medicines (NASDAQ:BPMC) through any online brokerage.
Other companies in Blueprint Medicines’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Sarepta Therapeutics (NASDAQ:SRPT).
Blueprint Medicines has a consensus price target of $110.04.
The stock price for Blueprint Medicines (NASDAQ: BPMC) is $91.68 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Blueprint Medicines.
Blueprint Medicines’s Q3 earnings are confirmed for Thursday, October 24, 2024.
There is no upcoming split for Blueprint Medicines.
Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.